Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
144
NMPA:144
Drug Approvals
Erythromycin Enteric-coated Tablets
- Product Name
- 红霉素肠溶片
- Approval Number
- 国药准字H13020896
- Approval Date
- Apr 30, 2025
NMPA
Paracetamol, Aminophenazone,Caffeine and Chlorphenamine Maleate Granules
- Product Name
- 酚氨咖敏颗粒
- Approval Number
- 国药准字H13024256
- Approval Date
- Mar 29, 2021
NMPA
Moroxydine Hydrochloride Tablets
- Product Name
- 盐酸吗啉胍片
- Approval Number
- 国药准字H13024271
- Approval Date
- Mar 29, 2021
NMPA
Compound Sulfamethoxydiazine Tablets
- Product Name
- 复方磺胺对甲氧嘧啶片
- Approval Number
- 国药准字H13023917
- Approval Date
- Mar 29, 2021
NMPA
Benactyzine Hydrochloride Tablets
- Product Name
- 盐酸贝那替嗪片
- Approval Number
- 国药准字H13023563
- Approval Date
- Mar 29, 2021
NMPA
Aurantium and Vitamin C Granules
- Product Name
- 维C橙皮苷颗粒
- Approval Number
- 国药准字H13023827
- Approval Date
- Mar 29, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found